Coin info
Rank
Market Cap
Volume (24h)
Circulating Supply
Total Supply
Do you think the price will rise or fall?
Rise 40%
Fall 60%
Price perfomance
Depth of Market
Depth +2%
Depth -2%


PRICE
+5.29%
$0.03305

PRICE
+4.34%
$1.89

PRICE
+4.34%
$0.001463

PRICE
+3.63%
$0.09848

PRICE
+3.13%
$0.05955

PRICE
+2.85%
$0.2141

PRICE
+2.58%
$2.91

PRICE
+1.88%
$76.44

PRICE
+1.84%
$0.05905

PRICE
+1.71%
$1.66

PRICE
+1.18%
$0.6473

PRICE
+1.08%
$0.1352

PRICE
+0.56%
$0.03400

PRICE
+0.50%
$44.51

PRICE
+0.43%
$0.3276

PRICE
+0.15%
$0.7823

PRICE
+0.14%
$0.9971

PRICE
+0.13%
$320.38

PRICE
+0.12%
$9.61

PRICE
+0.12%
$0.052

PRICE
+0.11%
$71.7

PRICE
+0.04%
$0.9998

PRICE
+0.04%
$1.0000

PRICE
+0.02%
$1.01

PRICE
+0.02%
$1.01

VOL24
+567.81%
$0.9988

VOL24
+538.46%
$2,111.46

VOL24
+214.88%
$0.9999

VOL24
+113.53%
$1.89

VOL24
+108.83%
$0.001463

VOL24
+80.19%
$0.9993

VOL24
+63.98%
$9.61

VOL24
+52.38%
$2.91

VOL24
+50.41%
$0.2141

VOL24
+49.3%
$0.9992

VOL24
+43.83%
$0.7817

VOL24
+42.68%
$4,129.06

VOL24
+41.38%
$0.7823

VOL24
+39.73%
$1.66

VOL24
+37.93%
$6.68

VOL24
+33.19%
$2.11

VOL24
+31.43%
$0.052

VOL24
+31.25%
$0.6029

VOL24
+27.62%
$44.51

VOL24
+25.7%
$0.03305

VOL24
+23.49%
$0.05955

VOL24
+21.04%
$0.05905

VOL24
+17.71%
$0.5274

VOL24
+14.27%
$0.08741

VOL24
+11.74%
$1.01

PRICE
+5.29%
$0.03305

PRICE
+4.34%
$1.89

PRICE
+4.34%
$0.001463

PRICE
+3.63%
$0.09848

PRICE
+3.13%
$0.05955

PRICE
+2.85%
$0.2141

PRICE
+2.58%
$2.91

PRICE
+1.88%
$76.44

PRICE
+1.84%
$0.05905

PRICE
+1.71%
$1.66

PRICE
+1.18%
$0.6473

PRICE
+1.08%
$0.1352

PRICE
+0.56%
$0.03400

PRICE
+0.50%
$44.51

PRICE
+0.43%
$0.3276

PRICE
+0.15%
$0.7823

PRICE
+0.14%
$0.9971

PRICE
+0.13%
$320.38

PRICE
+0.12%
$9.61

PRICE
+0.12%
$0.052

PRICE
+0.11%
$71.7

PRICE
+0.04%
$0.9998

PRICE
+0.04%
$1.0000

PRICE
+0.02%
$1.01

PRICE
+0.02%
$1.01

VOL24
+567.81%
$0.9988

VOL24
+538.46%
$2,111.46

VOL24
+214.88%
$0.9999

VOL24
+113.53%
$1.89

VOL24
+108.83%
$0.001463

VOL24
+80.19%
$0.9993

VOL24
+63.98%
$9.61

VOL24
+52.38%
$2.91

VOL24
+50.41%
$0.2141

VOL24
+49.3%
$0.9992

VOL24
+43.83%
$0.7817

VOL24
+42.68%
$4,129.06

VOL24
+41.38%
$0.7823

VOL24
+39.73%
$1.66

VOL24
+37.93%
$6.68

VOL24
+33.19%
$2.11

VOL24
+31.43%
$0.052

VOL24
+31.25%
$0.6029

VOL24
+27.62%
$44.51

VOL24
+25.7%
$0.03305

VOL24
+23.49%
$0.05955

VOL24
+21.04%
$0.05905

VOL24
+17.71%
$0.5274

VOL24
+14.27%
$0.08741

VOL24
+11.74%
$1.01
Rise 40%
Fall 60%


$0.8426
#2639
$1,607,203
$126.75
1,000,000
1,000,000
What is the project about? VitaDAO, a decentralized autonomous organization, introduces VITA-FAST, an innovative funding model for longevity research. Leveraging the Ethereum blockchain, VITA-FAST are ERC-20 tokens, signifying fractional ownership of the Intellectual Property Non-Fungible Token (IP-NFT) from longevity research conducted at the Korolchuk Lab, Newcastle University. VITA-FAST token holders gain governance rights over the IP, democratizing the decision-making processes in scientific research. 1. What is the project about? The project is focused on discovering and developing therapeutic compounds that can reactivate autophagy in Npc1 -/- cells. This involves screening bioactive and commercial small molecules in cell survival assays to identify potential autophagy activators that are not cytotoxic. The project uses advanced techniques like luciferase-p6 clearance and Halo-GFP-LC3 orthogonal assays for this purpose. 2. What makes your project unique? The project's uniqueness lies in its approach to identifying novel compounds that can induce autophagy in NPC1 -/- cells, a crucial process for treating Niemann-Pick Type C disease. Unlike existing treatments, this project employs high-throughput screening methods and innovative assays to discover compounds with high chemical variability and no similarity to existing autophagy inducers, opening up possibilities for new iIP. 3. History of your project. The project, led by Dr. Korolchuk and his team at Newcastle University, has progressed from generating data on thousands of compounds using advanced screening assays to identifying lead compounds with potential autophagic properties. It has evolved to include the synthesis of derivatives of these compounds and is now moving towards drug translation processes, including pharmacokinetics and scalability studies. 4. What’s next for your project? The next steps involve screening third-generation compounds, conducting in vitro and in vivo models using patient